Norihisa Tamura, Member of the House of Representatives and Former Minister of Health, Labour and Welfare, Confirmed to Speak at Ubie Pharma Summit 2026

Ubie Inc. (Headquarters: Chuo-ku, Tokyo; Co-CEOs: Yoshinori Abe, Kota Kubo), whose mission is to "guide people to the right medical care with technology," is pleased to announce that Norihisa Tamura, Member of the House of Representatives and Former Minister of Health, Labour and Welfare, will be a speaker at the "Ubie Pharma Summit 2026" (to be held on May 13-14, 2026, in Tokyo), a conference for pharmaceutical companies in which Ubie Inc. is participating as an executive committee member.

Apply Here

About "Ubie Pharma Summit" The "Ubie Pharma Summit" is a conference for pharmaceutical companies organized by the Ubie Pharma Summit Executive Committee. It aims to contribute to the further development of the industry by providing a platform for top industry leaders and innovators to gather and deepen discussions on mid-to-long-term challenges and the future of healthcare. This year, with "Integration" as the keyword, we will focus on the "Silos" that exist at various layers, including pharmaceutical industry systems, medical practice, and technology. By leveraging the innovative power of AI and the latest information technology, we will present a new concept of seamlessly "stitching together" these divisions from a patient-centric perspective. We aim to create a collaborative platform that transcends industry boundaries to fundamentally resolve the numerous "friction points" patients encounter in diagnosis and treatment processes, and to implement a true "patient-centered world."

Speakers (in Japanese alphabetical order) ＜Speakers＞ Reiko Akizuki: Executive Officer / Head of Medical Affairs, Amgen Inc. Chikato Ishida: Department Head, Respiratory/ENT Medical Department, Alliance Immunology, Specialty Care Medical Division, Sanofi K.K. Takashiko Iwaya: Representative Director and President, Sanofi K.K.; Chairman, European Federation of Pharmaceutical Industries Associations (EFPIA Japan) Shizuko Ueno: Director, Japan Business Unit Head, Japan Business Unit & Head of Medical Affairs, Daiichi Sankyo Company, Limited Osamu Okuda: President and CEO, Chugai Pharmaceutical Co., Ltd. Masataka Ogimura: Representative Director and President, Pharmaceutical Business Unit, Boehringer Ingelheim Japan Ltd. Hidehito Katsuma: Representative Director and President, Bristol Myers Squibb Company, Limited Jeremy Gussas: Representative Director and President, Merck Biopharma Co., Ltd. Simone Thomsen: Representative Director and President, Eli Lilly Japan K.K. John D. Halamka: President, Mayo Clinic Platform Dwight and Dian Diercks John Paul Prisino: Representative Director and President, Novartis Pharma K.K. Susana Murteira: Representative Director and President, Amgen Inc. Norihisa Tamura: Member of the House of Representatives, Former Minister of Health, Labour and Welfare Yukiyoshi Den: Representative Director and President, Biogen Japan Ltd.; Vice Chairman, Executive Committee, PhRMA Japan Takashi Naga: Head of Alliance Immunology Franchise, Specialty Care Business Unit, Sanofi K.K. Misako Hamamura: President, Alexion Pharma GK Chia-Ming Chang: Executive Officer and Business Unit Head, Hematology Oncology Business Unit, Novartis Pharma K.K. Toshihiro Maeda: Chief Operating Officer, Nextera Pharma Inc. & Representative Director and President, Nextera Pharma Japan Inc. Michelle Longmire: Co-founder & CEO, Medable Shuhei Morita: Representative Director and President, Fuji Yakuhin Co., Ltd. Masahiro Mori: Councilor for Pharmaceutical Industry Promotion and Medical Information, Minister's Secretariat, Ministry of Health, Labour and Welfare Shigeo Muro: Professor, Department of Respiratory Medicine, Nara Medical University; Working Group Member, Japan Society of Respiratory Society Project "Komorebi 2032" Kenji Yasukawa: Chairman of the Board, Astellas Pharma Inc. Yoshitake Yokokura: Chairman of the Board, Yokokura Hospital, Social Medical Corporation Koukeikai; Honorary Chairman, Japan Medical Association

*As of March 19, 2026

"Ubie Pharma Summit 2026" Overview Name: Ubie Pharma Summit 2026 Date: Day 1: Wednesday, May 13, 2026 Doors Open 9:30 / Main Program 10:00 - 18:30 (approx.) + Reception Day 2: Thursday, May 14, 2026 Doors Open 9:30 / Main Program 10:00 - 16:30 (approx.) + Reception Venue: Toranomon Hills Forum, 5F (Tokyo) *No Osaka venue is planned for this event. Participation Fee: Free Target Audience: Individuals belonging to pharmaceutical manufacturers (companies that manufacture and sell ethical drugs, over-the-counter drugs, investigational drugs, diagnostic reagents, and medical devices). *In addition, only individuals belonging to companies that do not have a competitive relationship with Ubie Inc. are eligible. We appreciate your understanding. URL: https://ph-ubie.com/ups/ubie_pharma_summit_2026?utm_source=prtimes&utm_medium=article&utm_campaign=ups202605_20260331-ct=text Press Kit: https://ph-ubie.com/ups/2026_presskit Organizer: Ubie Pharma Summit 2026 Executive Committee

*Simultaneous interpretation will be provided on the day. *This is not a lottery system. *Participation is possible for one day or even one program.

Inquiries Ubie Pharma Summit 2026 Executive Committee ubie-pharma-summit@dr-ubie.com

About Ubie Inc. Ubie Inc. is a health tech startup founded in May 2017 by a doctor and engineers, with the mission to "guide people to the right medical care with technology." Utilizing AI as its core technology, the company develops and provides services such as "Yubi," which guides users to appropriate medical care based on their symptoms, and "Ubie Medical Navi," a service package for medical institutions that supports improvements in the quality of medical practice. Ubie aims to create a society where everyone can access the medical care that suits them.

Location: 5F, Nihonbashi Life Science Building 4, 3-8-4 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023 Established: May 2017 Representatives: Co-CEO, MD Yoshinori Abe; Co-CEO Kota Kubo URL: https://ubie.life